Ronald G. Tilton, Ph.D.
Professor, Division of Endocrinology
Ronald G. Tilton, Ph.D.
Division of Endocrinology
Department of Internal Medicine
University of Texas Medical Branch
8.138 Medical Research Building
Galveston, Texas 77555-1060
Dr. Tilton is a senior research scientist with 40 years experience working in the field of diabetic complications. His research has focused on the role of excessive glucose metabolism in the pathogenesis of diabetic complications, and he has developed techniques that measure vascular permeability and blood flow, and utilized light microscopy, immunofluorescence, transmission and scanning electron microscopy to explore vascular functional and structural changes induced by both type 1 and type 2 diabetes in kidneys and eyes. Currently, Dr. Tilton's research is focused on inflammatory changes in diabetic kidneys, and he uses biochemistry, tissue culture, and molecular biology approaches to explore the role of renal tubular epithelium in diabetes-induced renal inflammation.
Dr. Tilton has 10 years experience performing mass spectrometry/proteomic studies of diabetic tissues. The overall objective of this research is to identify all proteins globally affected by increased VEGF expression in diabetic eyes and kidneys, then use bioinformatics-based tools to explore molecular mechanisms of VEGF action in the pathogenesis of diabetic complications. In addition to research, Dr. Tilton is actively involved in teaching medical and graduate students, postdoctoral fellows, and residents, and he mentors junior faculty. He serves as vice-Chair of the UTMB Institutional Animal Care and Use Committee. When not occupied by his teaching, research, and administrative responsibilites for UTMB, Dr. Tilton helps his wife operate her Texas Hill Country restaurant.
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.Currently available protocols are:
- CAP - Community Acquired Pneumonia Order set
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medications
- Parenteral Opioids
- Sepsis, Adult ICU
- 111 - Stroke Alert
- 112 - Stroke Activation
- 300086 - Stroke Floor Admission
- 3000000001 - Stroke Critical care without tPA
- 300088 Stroke - Transfer from Critical care to floor
- 3004002 - Stroke Discharge
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.